Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Gh Research Plc (NQ: GHRS ) 6.410 -0.280 (-4.19%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 1, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Gh Research Plc < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > Psychedelic Drug Stocks +6% Last Week Vs. -13% Previous Week September 15, 2024 The psychedelic compound-based drug market is expected to triple over the next few years, creating many winning stocks in the years to come. Via Talk Markets Psychedelic Compound-Based Drug Stocks Portfolio -13% W/e Sept. 6th September 10, 2024 While the psychedelic compound-based drug market is expected to triple over the next few years which should create many winning stocks in the years to come, the stocks of the companies involved are... Via Talk Markets Our Psychedelic Compound-Based Clinical-Stage Drug Stocks Portfolio Was Down 16% In August September 06, 2024 The psychedelic compound-based drug market is expected to triple over the next few years which should create many winning stocks in the years to come and, to monitor their progress we present a... Via Talk Markets Irish Biotech Firm GH Research Sees Cash Decline in Q2, Advances Psychedelic Drug Trials September 05, 2024 Irish psychedelic biotech firm GH Research PLC (NASDAQ: GHRS) reported on Tuesday financial results for the second quarter ended June 30, 2024. Cash, cash equivalents, other financial assets and... Via Benzinga GH Research Reports Second Quarter 2024 Financial Results and Provides Business Updates September 03, 2024 From GH Research PLC Via GlobeNewswire GH Research: Q4 Earnings Insights February 29, 2024 Via Benzinga GH Research Announces Appointment of Dr. Velichka “Villy” Valcheva to Chief Executive Officer September 03, 2024 From GH Research PLC Via GlobeNewswire Largest Psychedelic Compound -Based Clinical-Stage Drug Stocks Up 6% Last Week August 24, 2024 Opportunities to invest in psychedelic stocks are emerging for those willing to get in early, and the 4 largest psychedelic compound-based portfolio drug discovery companies are up 5.9% in the past... Via Talk Markets Psychedelic Compound-Based Drug Stocks Portfolio: Up 17.5% In July; Down 19% MTD August 15, 2024 This article highlights the 4 largest market cap clinical-stage psychedelic compound-based drug discovery companies with their stock performances MTD, in July, their areas of focus, and their latest... Via Talk Markets Clinical-Stage BioTech Drug Stocks Jumped 10% Last Week; UP 13% MTD July 14, 2024 The 10 clinical-stage AI-focused and psychedelic compound-based drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio are UP 12.8% MTD after having gone DOWN 13.2%, on average,... Via Talk Markets 3 Psychedelic Stocks to Ride to the Moon and Beyond July 06, 2024 Psychedelic stocks are a hot, trending area of investment as the FDA continues to weigh regulatory considerations that will open the market. Via InvestorPlace Exposures Product Safety Psychedelic Picks: 3 Trippy Stocks Aiming for Out-of-This-World Returns July 03, 2024 Psychedelics could be a game-changer in treating mental health issues, creating substantial opportunities for top psychedelic stocks. Via InvestorPlace Largest Clinical-Stage BioTech Drug Stocks Declined 6% June 22, 2024 Of the 10 clinical-stage AI-focused and psychedelic compound-based small cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, only 1 advanced this week. On average they... Via Talk Markets Largest Psychedelic Compound Based Drug Stocks Fell 13% Last Week - Here's Why June 09, 2024 Stocks for companies developing psychedelic treatments fell last Wednesday after advisers to the Food and Drug Administration voted against a mental-health therapy using the drug MDMA. Via Talk Markets 12 Health Care Stocks Moving In Wednesday's Intraday Session June 05, 2024 Via Benzinga Largest Clinical-Stage BioTech Drug Stocks Declined Slightly Last Week May 27, 2024 This article highlights the performances last week and MTD of the 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies along with their areas of focus in our... Via Talk Markets Largest Clinical-Stage BioTech Drug Stocks Declined 3% Last Week May 13, 2024 Via Talk Markets Clinical-Stage BioTech Drug Stocks Portfolio Jumped 7% In First Week Of May May 05, 2024 We look at the performance of 10 clinical-stage AI-powered and psychedelic compound-based small cap drug discovery companies during the first week of May and YTD. Via Talk Markets GHRS Stock Earnings: GH Research Beats EPS for Q1 2024 May 03, 2024 GHRS stock results show that GH Research beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace GH Research Reports First Quarter 2024 Financial Results and Provides Business Updates May 03, 2024 From GH Research PLC Via GlobeNewswire Clinical-Stage BioTech Drug Stocks Portfolio Went Down 9% Last Week April 23, 2024 A look at the 10 clinical-stage AI-powered and psychedelic compound-based small-cap drug discovery companies in our Clinical-Stage BioTech Drug Stocks Portfolio, their stock performances last week and... Via Talk Markets Psyched: DEA Revisits Ban On Two Psychedelics, Farewell Russell Newcombe, Podcast Episode On Kanna & More April 17, 2024 Via Benzinga Largest Psychedelic Drug Stocks Up Another 10% Last Week; Now Up 54% YTD April 12, 2024 The 5 constituents in the Psychedelic Compound-Based Drug Stocks Index were up 10.0%, on average, last week and are now up 53.9% YTD. Via Talk Markets March Recap: Largest Psychedelic Drug Stocks Up Another 5% March 30, 2024 The 5 constituents in the munKNEE Psychedelic Compound-Based Drug Stocks Index were UP 5.4%, on average, in March and are now UP 39.9% YTD. Via Talk Markets Psyched: 5-MeO-DMT For Depression, Utah Hospitals Providing Therapy, Elon Musk And Meta's Influence March 29, 2024 Via Benzinga Psyched: LSD, Psilocybin As Breakthrough Therapies, $14M Fed Grant For Ibogaine, Indiana's Research And More March 20, 2024 Via Benzinga Topics Economy Exposures Interest Rates Psychedelic Compound-Based Drug Stock, Mind Medicine, Up 56% Last Week March 11, 2024 The FDA has granted breakthrough designation to Mind Medicine's program for the treatment of generalized anxiety disorder. Via Talk Markets Exposures Product Safety Psyched: New Evidence Shows Psilocybin As Anxiety Therapy, Open-Source Learning For Therapists, Enveric's Licensing Deals And More March 04, 2024 Via Benzinga Largest Psychedelic Compound-Based Drug Stocks Up 15% In February; Now Up 33% YTD March 01, 2024 The Psychedelic Compound-Based Drug Stocks Index was up 15.0% in February led by Incannex Healthcare which was up 55.1%. Via Talk Markets GH Research: This European Biotech Company Reports Full Year 2023 Financial Results And Business Updates February 29, 2024 Via Benzinga < Previous 1 2 3 4 5 6 7 8 9 ... 17 18 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.